04:26:16 EDT Sat 17 Apr 2021
Enter Symbol
or Name
USA
CA



Q:BLUE - BLUEBIRD BIO INC - http://www.bluebirdbio.com/04:26:16 EDT
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
BLUE - Q0.128.14·28.360.928.28-1.44-4.82,452.469,49915,10029.325  29.84  27.9972.505  24.2419:57:53Apr 1215 min RT 2¢

Recent Trades - Last 10 of 15100
Time ETExPriceChangeVolume
19:57:53Q28.29-1.438
19:57:53Q28.36-1.368
19:11:28Q28.12-1.6010
18:49:34Q28.20-1.5231
18:49:34Q28.18-1.5410
18:49:34Q28.12-1.609
18:41:19Q28.20-1.5215
18:40:27Q28.29-1.432
18:13:28Q28.07-1.651
18:09:53Q28.07-1.651

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent BulletinsNews ReleasesIn The NewsOther
Date ETSymbolTypeHeadline
2021-04-12 16:00U:BLUENews ReleaseDEADLINE TUESDAY ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against bluebird bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
2021-04-12 15:48U:BLUENews ReleaseBLUE INVESTOR FILING DEADLINE TOMORROW : Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Has Been Filed Against bluebird bio, Inc.
2021-04-11 06:22U:BLUENews ReleaseTUESDAY DEADLINE ALERT: ROSEN, A TOP RANKED FIRM, Encourages bluebird bio, Inc. Investors With Losses Over $100K to Secure Counsel Before Important April 13 Deadline in Securities Class Action - BLUE
2021-04-09 10:00U:BLUENews ReleaseThe Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against bluebird bio, Inc. (BLUE)
2021-04-06 01:35U:BLUENews ReleaseSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in bluebird bio, Inc. of Class Action Lawsuit and Upcoming Deadline - BLUE
2021-04-04 03:47U:BLUENews ReleaseSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in bluebird bio, Inc. of Class Action Lawsuit and Upcoming Deadline - BLUE
2021-03-31 02:48U:BLUENews ReleaseSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in bluebird bio, Inc. of Class Action Lawsuit and Upcoming Deadline - BLUE
2021-03-26 22:59U:BLUENews ReleaseU.S. Food and Drug Administration Approves Bristol Myers Squibb ’s and bluebird bio ’s Abecma (idecabtagene vicleucel), the First Anti-BCMA CAR T Cell Therapy for Relapsed or Refractory Multiple Myeloma
2021-03-24 03:39U:BLUENews ReleaseSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in bluebird bio, Inc. of Class Action Lawsuit and Upcoming Deadline - BLUE
2021-03-20 18:20U:BLUENews ReleaseROSEN, A LEADING LAW FIRM, Encourages bluebird bio, Inc. Investors with Large Losses to Secure Counsel Before Important April 13 Deadline in Securities Class Action - BLUE